About this document

Ocular Drug Delivery with Lyotropic Liquid Crystals by ANIE is a document available to read on EtoBox.

This review discusses the advancements in lyotropic liquid crystals (LLCs) for ocular drug delivery, highlighting their ability to enhance bioavailability, prolong retention, and facilitate controlled release. It emphasizes the integration of predictive modeling and biosensing technologies to optimize LLC formulations, addressing the limitations of traditional ocular drug delivery methods. The findings suggest that LLCs have significant potential to improve therapeutic outcomes for various ocular diseases,

Author

ANIE

Language

EN